武汉纽福斯生物科技有限公司 Wuhan Neurophth Biotechnology Co. LTD

Latest News

Neurophth Announces IND Approval by the NMPA for Leber Hereditary Optic Neuropathy Gene Therapy

WUHAN and SUZHOU, China, April 1, 2021 /PRNewswire/ -- Neurophth Biotechnology Ltd., a fully-integr...

2021-04-01 20:39 4024

Neurophth Closes RMB 400 Million Series B Financing

Proceeds to support – * continued development of robust portfolio of AAV-delivered therapeutics ...

2021-02-09 21:44 1111

Neurophth Therapeutics Further Expands Ocular Gene Therapy Expertise with Appointment of Qiutang Li, Ph.D., as Chief Scientific Officer

WUHAN, China and NEWARK, Del., Jan. 27, 2021 /PRNewswire/ -- Wuhan Neurophth Biotechnology Ltd., a ...

2021-01-27 21:00 689

Neurophth and AAVnerGene Enter Strategic AAV Capsids Partnership for Next-Generation Ophthalmic Gene Therapy

WUHAN, China and NEWARK, DE., Jan. 19, 2021 /PRNewswire/ -- Neurophth Therapeutics, Inc., a subsidi...

2021-01-19 14:05 586

Neurophth Therapeutics' Treatment of Leber's Hereditary Optic Neuropathy Gene Therapy NR082 was Granted Orphan Drug Designation by U.S. FDA

NEWARK, Del., Sept. 24, 2020 /PRNewswire/ -- Neurophth Therapeutics, Inc., (hereinafter referred to...

2020-09-25 10:37 1156

Neurophth Therapeutics Announces Presentations at ASGCT and ARVO Annual Meetings

BOSTON and WUHAN, China, May 11, 2020 /PRNewswire/ -- Neurophth Therapeutics, Inc., a clinical-stag...

2020-05-11 20:00 792